New Key Statistics Module, Z-Score and F-Score
OCSE:SMSMED Key Ratios
| Market Cap kr M | 190.86 |
| Enterprise Value kr M | 225.87 |
| P/E(ttm) | 34.30 |
| PE Ratio without NRI | 34.30 |
| Forward PE Ratio | -- |
| Price/Book | 2.44 |
| Price/Sales | 0.95 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 197.00 |
| EPS (TTM) kr | 0.20 |
| Beneish M-Score | -0.89 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -42.50 |
| EV-to-EBIT | 28.05 |
| EV-to-EBITDA | 15.89 |
| PEG | -- |
| Shares Outstanding M | 27.50 |
| Net Margin (%) | 2.72 |
| Operating Margin % | 4.32 |
| Pre-tax Margin (%) | 3.54 |
| Quick Ratio | 0.45 |
| Current Ratio | 1.67 |
| ROA % (ttm) | 3.58 |
| ROE % (ttm) | 7.21 |
| ROIC % (ttm) | 5.76 |
| Dividend Yield % | -- |
| Altman Z-Score | 3.74 |
OCSE:SMSMED Number of Guru Trades
OCSE:SMSMED Volume of Guru Trades
Gurus Latest Trades with OCSE:SMSMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OCSE:SMSMED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers